BiomOrgan was delighted to attend MedTech World Asia 2026 in Hong Kong, a leading conference that brought together innovators, researchers, and industry leaders to explore the future of healthcare technology.

Our Chief Operating Officer, Benson To, represented BiomOrgan at the event, engaging with peers and exploring the latest developments in biotechnology, precision medicine, and digital health. Participation in MedTech World Asia reflects BiomOrgan’s commitment to collaboration and innovation.

The perspectives gained will guide our mission to advance biotechnology and deliver meaningful solutions for patients and healthcare systems worldwide.

>> Learn more about BiomOrgan’s initiatives at bd@biomorgan.hk